CheckMate-142CheckMate-142gastrointestinal cancersimmunotherapyThe Cancer Genome AtlasKEYNOTE-177KEYNOTE-059TCGAgastric cancers
…SI-high tumors, PD-L1 status did not distinguish responders; in CheckMate-142, response rates were comparable, i.e 46% for PD-L1-positive and…